Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary cutaneous melanoma risk stratification using a clinicopathologic and gene expression model: a pilot study.
Arias-Mejias SM, Quattrocchi E, Tempel D, Luna-Vargas M, Chen J, Murphree DH, Gjorgova Gjeorgjievski S, Lehman JS, Bridges AG, Dwarkasing J, Meves A. Arias-Mejias SM, et al. Among authors: tempel d. Int J Dermatol. 2020 Nov;59(11):e431-e433. doi: 10.1111/ijd.14987. Epub 2020 Jun 9. Int J Dermatol. 2020. PMID: 32516450 Free PMC article. No abstract available.
Validation of a clinicopathological and gene expression profile model for sentinel lymph node metastasis in primary cutaneous melanoma.
Mulder EEAP, Dwarkasing JT, Tempel D, van der Spek A, Bosman L, Verver D, Mooyaart AL, van der Veldt AAM, Verhoef C, Nijsten TEC, Grunhagen DJ, Hollestein LM. Mulder EEAP, et al. Among authors: tempel d. Br J Dermatol. 2021 May;184(5):944-951. doi: 10.1111/bjd.19499. Epub 2020 Nov 2. Br J Dermatol. 2021. PMID: 32844403 Free PMC article.
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I-II Melanoma Patients at Risk of Disease Relapse.
Mulder EEAP, Johansson I, Grünhagen DJ, Tempel D, Rentroia-Pacheco B, Dwarkasing JT, Verver D, Mooyaart AL, van der Veldt AAM, Wakkee M, Nijsten TEC, Verhoef C, Mattsson J, Ny L, Hollestein LM, Olofsson Bagge R. Mulder EEAP, et al. Among authors: tempel d. Cancers (Basel). 2022 Jun 9;14(12):2854. doi: 10.3390/cancers14122854. Cancers (Basel). 2022. PMID: 35740520 Free PMC article.
Time course of VCAM-1 expression in reperfused myocardial infarction in swine and its relation to retention of intracoronary administered bone marrow-derived mononuclear cells.
Uitterdijk A, Groenendijk BCW, Gorsse-Bakker C, Panasewicz A, Sneep S, Tempel D, van de Kamp EH, Merkus D, van der Giessen WJ, Duncker DJ. Uitterdijk A, et al. Among authors: tempel d. PLoS One. 2017 Jun 19;12(6):e0178779. doi: 10.1371/journal.pone.0178779. eCollection 2017. PLoS One. 2017. PMID: 28628621 Free PMC article.
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay.
Kuiper R, Wright VJ, Habgood-Coote D, Shimizu C, Huigh D, Tremoulet AH, van Keulen D, Hoggart CJ, Rodriguez-Manzano J, Herberg JA, Kaforou M, Tempel D, Burns JC, Levin M. Kuiper R, et al. Among authors: tempel d. Pediatr Res. 2023 Feb;93(3):559-569. doi: 10.1038/s41390-022-02148-y. Epub 2022 Jun 22. Pediatr Res. 2023. PMID: 35732822 Free PMC article.
Feasibility of intracoronary GLP-1 eluting CellBead™ infusion in acute myocardial infarction.
Houtgraaf JH, de Jong R, Monkhorst K, Tempel D, van de Kamp E, den Dekker WK, Kazemi K, Hoefer I, Pasterkamp G, Lewis AL, Stratford PW, Wallrapp C, Zijlstra F, Duckers HJ. Houtgraaf JH, et al. Among authors: tempel d. Cell Transplant. 2013;22(3):535-43. doi: 10.3727/096368912X638973. Epub 2012 Apr 10. Cell Transplant. 2013. PMID: 22507673 Free article.
75 results